Element Pointe Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Element Pointe Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-62,775	Closed	-$5.96M	–	78
2024 Q1	$5.96M	Buy	62,775 +9,769	+18%	+$906K	1.53%	12
2023 Q4	$4.73M	Buy	53,006 +16,077	+44%	+$1.19M	1.14%	20
2023 Q3	$2.7M	Buy	36,929 +11,927	+48%	+$953K	0.69%	22
2023 Q2	$2.08M	Sell	25,002 -871	-3%	-$72.8K	0.54%	24
2023 Q1	$1.97M	Sell	25,873 -1,315	-5%	-$109K	0.53%	23
2022 Q4	$2.26M	Sell	27,188 -6,639	-20%	-$537K	0.7%	20
2022 Q3	$2.68M	Sell	33,827 -4,337	-11%	-$366K	1.54%	12
2022 Q2	$2.83M	Buy	38,164 +11,636	+44%	+$873K	1.18%	15
2022 Q1	$2.38M	Buy	+26,528	New	+$2.45M	0.8%	19

Other funds holding XBI

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Element Pointe Advisors's XBI Position: Q2 2024 in Review

Element Pointe Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 62,775 shares — an estimated $5.96M sold.

Element Pointe Advisors first reported a position in XBI in Q1 2022 and held it in 9 quarters. The position peaked at $5.96M in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Element Pointe Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Element Pointe Advisors sold 62,775 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $5.96M.
Element Pointe Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 9 quarters.
Element Pointe Advisors's State Street SPDR S&P Biotech ETF position peaked at $5.96M in Q1 2024.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Element Pointe Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.